XOMA Royalty Corporation (XOMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, XOMA Royalty Corporation (XOMA) has a cash flow conversion efficiency ratio of -0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.50 Million) by net assets ($103.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
XOMA Royalty Corporation - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how XOMA Royalty Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read XOMA Royalty Corporation total liabilities for a breakdown of total debt and financial obligations.
XOMA Royalty Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of XOMA Royalty Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Home Bancorp Inc
NASDAQ:HBCP
|
0.038x |
|
Addiko Bank AG
VI:ADKO
|
N/A |
|
Bingshan Refrigeration & Heat Transfer Technologies Co Ltd
SHE:000530
|
-0.003x |
|
Stylam Industries Limited
NSE:STYLAMIND
|
0.104x |
|
Sumitomo Mitsui Construction Co. Ltd
F:72S
|
N/A |
|
Cooper Stnd
NYSE:CPS
|
0.560x |
|
Sichuan Fulin Transportation Group Co Ltd
SHE:002357
|
0.006x |
|
POSCO M-TECH Co. Ltd
KQ:009520
|
-0.006x |
Annual Cash Flow Conversion Efficiency for XOMA Royalty Corporation (1989–2025)
The table below shows the annual cash flow conversion efficiency of XOMA Royalty Corporation from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see XOMA market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $103.96 Million | $2.87 Million | 0.028x | +116.46% |
| 2024-12-31 | $81.92 Million | $-13.75 Million | -0.168x | +18.00% |
| 2023-12-31 | $88.72 Million | $-18.16 Million | -0.205x | -97.07% |
| 2022-12-31 | $124.01 Million | $-12.88 Million | -0.104x | -164.97% |
| 2021-12-31 | $141.88 Million | $22.68 Million | 0.160x | +36.88% |
| 2020-12-31 | $86.42 Million | $10.09 Million | 0.117x | +1902.32% |
| 2019-12-31 | $43.99 Million | $-285.00K | -0.006x | +99.04% |
| 2018-12-31 | $18.79 Million | $-12.64 Million | -0.673x | -244.99% |
| 2017-12-31 | $5.79 Million | $2.69 Million | 0.464x | -34.95% |
| 2016-12-31 | $-47.21 Million | $-33.69 Million | 0.714x | -94.67% |
| 2015-12-31 | $-2.31 Million | $-30.89 Million | 13.379x | +152.96% |
| 2014-12-31 | $3.10 Million | $-78.28 Million | -25.260x | -319.35% |
| 2013-12-31 | $-3.99 Million | $-45.91 Million | 11.516x | +706.45% |
| 2012-12-31 | $21.47 Million | $-40.77 Million | -1.899x | +1.92% |
| 2011-12-31 | $15.01 Million | $-29.06 Million | -1.936x | +13.06% |
| 2010-12-31 | $23.59 Million | $-52.54 Million | -2.227x | -624.95% |
| 2009-12-31 | $17.53 Million | $7.43 Million | 0.424x | -59.60% |
| 2008-12-31 | $-31.40 Million | $-32.98 Million | 1.050x | -92.65% |
| 2007-12-31 | $318.00K | $4.54 Million | 14.286x | +1539.15% |
| 2006-12-31 | $-38.17 Million | $-33.27 Million | 0.872x | -59.23% |
| 2005-12-31 | $-20.67 Million | $-44.19 Million | 2.138x | +17.36% |
| 2004-12-31 | $-24.61 Million | $-44.83 Million | 1.821x | +284.74% |
| 2003-12-31 | $48.21 Million | $-47.54 Million | -0.986x | -132.16% |
| 2002-12-31 | $-11.37 Million | $-34.84 Million | 3.066x | +286.21% |
| 2001-12-31 | $13.62 Million | $-22.42 Million | -1.646x | -162.96% |
| 2000-12-31 | $-8.59 Million | $-22.46 Million | 2.615x | +2.53% |
| 1999-12-31 | $-16.90 Million | $-43.10 Million | 2.550x | +101.35% |
| 1998-12-31 | $200.00K | $-37.70 Million | -188.500x | -48910.00% |
| 1997-12-31 | $31.20 Million | $-12.00 Million | -0.385x | +40.42% |
| 1996-12-31 | $34.70 Million | $-22.40 Million | -0.646x | +40.14% |
| 1995-12-31 | $26.80 Million | $-28.90 Million | -1.078x | -64.59% |
| 1994-12-31 | $43.50 Million | $-28.50 Million | -0.655x | -77.74% |
| 1993-12-31 | $78.40 Million | $-28.90 Million | -0.369x | +4.61% |
| 1992-12-31 | $88.50 Million | $-34.20 Million | -0.386x | -88.32% |
| 1991-12-31 | $134.50 Million | $-27.60 Million | -0.205x | +76.03% |
| 1990-12-31 | $26.40 Million | $-22.60 Million | -0.856x | -26.77% |
| 1989-12-31 | $27.10 Million | $-18.30 Million | -0.675x | -- |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more